Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Quality control release of the cobas c501 igg-2 (tina quant igg gen. 2) cassette showed a too low recovery of the precinorm puc control target value while using the cerebrospinal fluid (csf) application.